Corteva (NYSE:CTVA) Releases FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) issued an update on its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 3.450-3.700 for the period, compared to the consensus estimate of 3.650. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.1 billion.

Corteva Stock Up 2.7%

NYSE:CTVA traded up $2.22 on Tuesday, reaching $83.91. The stock had a trading volume of 5,008,023 shares, compared to its average volume of 3,983,275. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a 50-day moving average of $80.39 and a 200 day moving average of $72.18. The stock has a market cap of $56.33 billion, a P/E ratio of 53.11, a price-to-earnings-growth ratio of 2.77 and a beta of 0.59. Corteva has a 12-month low of $60.53 and a 12-month high of $85.63.

Corteva (NYSE:CTVA) last posted its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The firm’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same period in the prior year, the company posted $0.32 EPS. On average, research analysts predict that Corteva will post 3.62 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva’s dividend payout ratio is 45.57%.

Analyst Ratings Changes

CTVA has been the topic of a number of recent analyst reports. Royal Bank Of Canada upped their target price on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Friday, April 24th. Oppenheimer upped their target price on shares of Corteva from $86.00 to $89.00 and gave the company an “outperform” rating in a research note on Wednesday, April 22nd. JPMorgan Chase & Co. cut Corteva from an “overweight” rating to a “neutral” rating and upped their price objective for the company from $75.00 to $77.00 in a research note on Thursday, February 5th. Weiss Ratings restated a “hold (c)” rating on shares of Corteva in a research note on Wednesday, April 22nd. Finally, Wells Fargo & Company upped their price objective on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $86.38.

Insider Transactions at Corteva

In other news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.15% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Corteva

Several institutional investors have recently modified their holdings of CTVA. Brighton Jones LLC grew its position in Corteva by 307.2% in the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the last quarter. Insigneo Advisory Services LLC bought a new stake in shares of Corteva during the fourth quarter valued at approximately $234,000. American Trust raised its holdings in shares of Corteva by 11.4% during the fourth quarter. American Trust now owns 3,497 shares of the company’s stock valued at $234,000 after buying an additional 357 shares during the last quarter. PCM Encore LLC acquired a new position in shares of Corteva during the fourth quarter worth approximately $231,000. Finally, L2 Asset Management LLC grew its holdings in Corteva by 7.3% in the 4th quarter. L2 Asset Management LLC now owns 3,427 shares of the company’s stock worth $230,000 after buying an additional 232 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.